Advertisement

Topics

Search Results for "New Arthritis Medication 2012"

06:12 EDT 22nd October 2017 | BioPortfolio

Matching Channels

Matching News

Medication errors haven’t gone away

A 10-year analysis of medical malpractice cases indicates that medication errors continue to represent a significant risk to patients and health care providers, despite myriad efforts to eliminate tha...

Rheumatoid Arthritis Patients Shun Medical Advice

NHS Prescription Charges Stop Patients Receiving Life-Changing Medication  The National Rheumatoid Arthritis Society (NRAS) today releases four shocking statistics to highlight how the cost of an NHS...

Early intervention in pre-rheumatoid arthritis reduces risk of rheumatoid arthritis

Early therapeutic intervention in people with pre-rheumatoid arthritis significantly reduces the risk of the occurrence of rheumatoid arthritis 52 weeks later, experts highlight at the Annual European...

UK’s largest arthritis charities merge

Arthritis Care will merge into Arthritis Research UK and work as one charity from October 2017. Talks between the two organisations began at the start of the year, and after careful consideration it w...

Arthritis Can Strike Children

TUESDAY, Oct. 17, 2017 -- While arthritis is typically thought of as an older person's disease, more than 300,000 American children have chronic juvenile idiopathic arthritis (JIA), an expert says. Un...

Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis

Inflammatory arthritis (IA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA), leads to increased cardiovascular disease occurrence probably due to athero...

Rheumatoid arthritis: What you should know

Arthritis is an umbrella term used to describe inflammation in the joints. Rheumatoid arthritis is a type of persistent arthritis that affects joints on both sides of the body, such as the hands, wris...

Eli Lilly to refile RA remedy to FDA

Michael JohnsenBaricitinib is a once-daily oral investigational medication for the treatment of patients with moderate-to-severe rheumatoid arthritis. read more

Matching PubMed Articles

Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions.

Self-injectable TNF inhibitors are increasingly used early in the chronic treatment of moderate to severe rheumatologic conditions. We estimated medication adherence/persistence over time following in...

Trends in medication use by body mass index and age between 1988 and 2012 in the United States.

Whether the increase in prescription medication use over time differs by age and obesity status is unclear.

The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.

Medication errors may lead to adverse drug events (ADEs), which endangers patient safety and increases healthcare-related costs. The on-ward deployment of clinical pharmacists has been shown to reduce...

Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.

AbbVie provides a free-to-patient patient support program (PSP) to assist adalimumab-treated patients with medication costs, nurse support, injection training, pen disposal, and medication reminders. ...

Effects of a Web-Based Patient Decision Aid on Biologic and Small Molecule Agents for Rheumatoid Arthritis, ANSWER-2: A Proof-of-Concept Study.

To assess the extent to which ANSWER-2, an interactive online patient decision aid, reduces patients' decisional conflict and improves their medication-related knowledge and self-management capacity.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement